Skip to main content
Quantum Biopharma Ltd. logo

Quantum Biopharma Ltd. — Investor Relations & Filings

Ticker · QNTM ISIN · CA74764Y2050 US Manufacturing
Filings indexed 336 across all filing types
Latest filing 2025-12-11 Foreign Filer Report
Country US United States of America
Listing US QNTM

About Quantum Biopharma Ltd.

https://www.quantumbiopharma.com/

Quantum Biopharma Ltd. is a biopharmaceutical company developing a portfolio of assets for neurodegenerative, neuropsychiatric, and inflammatory disorders. The company's lead pharmaceutical candidate is Lucid-MS, a patented, first-in-class neuroprotective compound for Multiple Sclerosis that targets myelin repair and has completed Phase 1 human clinical trials. Alongside its drug development pipeline, Quantum Biopharma is launching unbuzzd™, a functional beverage designed to support mental alertness and detoxification following alcohol consumption. The company's dual strategy focuses on both advanced pharmaceutical research and development and consumer wellness products.

Recent filings

Filing Released Lang Actions
6-K/A
Foreign Filer Report
2025-12-11 English
6-K
Foreign Filer Report
2025-12-08 English
FORM 6-K
Foreign Filer Report
2025-12-01 English
FORM 6-K
Foreign Filer Report
2025-11-28 English
FORM 6-K
Foreign Filer Report
2025-11-26 English
FORM 6-K
Foreign Filer Report
2025-11-25 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.